Validation of human papillomavirus genotyping by signature DNA sequence analysis

BMC Clinical Pathology

Volumn 9, Issue 1, 2009, Pages

  Lee, Sin Hang ^a   Vigliotti, Veronica S ^a   Vigliotti, Jessica S ^a   Pappu, Suri ^a  

^a Milford Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; DNA EXTRACTION; DNA PURIFICATION; DNA SEQUENCE; GENETIC DATABASE; GENOTYPE; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 58; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; SCREENING TEST; SEQUENCE ALIGNMENT; UNITED STATES; VALIDATION STUDY; VIRUS DETECTION; VIRUS ISOLATION; WART VIRUS;

EID: 66949115325     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-9-3     Document Type: Article

References (41)

1. CDC's Advisory Committee Recommends Human Papillomavirus Virus Vaccination. Centers of Disease Control and Prevention, http://www.cdc.gov/od/ oc/media/pressrel/r060629.htm
2. Detailed Guide: Cervical Cancer-What Are the Key Statistics About Cervical Cancer? American Cancer Society, http://www.cancer.org/docroot/CRI/ content/CRI-2-4-1X-What-are-the-key-statistics-for-cervical-cancer-8.asp
3. Findings to date from the ASCUS-LSIL Triage Study (ALTS). M Schiffman D Solomon, Arch Pathol Lab Med 2003 127 946 949 12873166 (Pubitemid 36994853)
4. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. TC Wright Jr M Schiffman D Solomon JT Cox F Garcia S Goldie K Hatch KL Noller N Roach C Runowicz D Saslow, Obstet Gyne col 2004 103 304 309 14754700
5. Human Papillomavirus. ACOG Practice Bulletin No. 61, Obstet Gynecol 2005 105 905 918 15802436
6. HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance. LS Massad MF Schneider DH Watts HD Strickler S Melnick J Palefsky K Anastos AM Levine H Minkoff, J Womens Health (Larchmt) 2004 13 147 53 15072728
7. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation. NM Lonky JC Felix YM Naidu G Wolde-Tsadik, Obstet Gynecol 2003 101 481 489 10.1016/S0029-7844(02)02715-1 12636951
8. Atypical squamous cells of undetermined significance, human papillomavirus, and cervical intraepithelial neoplasia 2 or 3 in adolescents: ASC-US, age, and high-grade cervical neoplasia. LA Boardman S Weitzen C Stanko, J Low Genit Tract Dis 2006 10 140 145 10.1097/00128360-200607000-00004 16829752
9. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. G Ronco J Cuzick N Segnan S Brezzi F Carozzi S Folicaldi P Dalla Palma A Del Mistro A Gillio-Tos P Giubilato C Naldoni E Polla A Iossa M Zorzi M Confortini P Giorgi-Rossi NTCC working group, Eur J Cancer 2007 43 476 480 10.1016/j.ejca.2006.11.013 17223540
10. Trade-offs in cervical cancer prevention: balancing benefits and risks. NK Stout JD Goldhaber-Fiebert JD Ortendahl SJ Goldie, Arch Intern Med 2008 168 1881 1889 10.1001/archinte.168.17.1881 18809815
11. Human papillomavirus testing and reporting rates: practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006. AT Moriarty MR Schwartz G Eversole M Means A Clayton R Souers L Fatheree WD Tench M Henry DC Wilbur, Arch Pathol Lab Med 2008 132 1290 1294 18684028
12. Achieving quality reproducible results and maintaining compliance in molecular diagnostic testing of human papillomavirus. JM Seabrook RA Hubbard, Arch Pathol Lab Med 2003 127 978 983 12873170 (Pubitemid 36994858)
13. College of American Pathologists Practice patterns in HPV testing. AH Fischer, CAP Today. August issue 2008
14. The Expanded Use of HPV Testing in Gynecologic Practice per ASCCP-Guided Management Requires the Use of Well-Validated Assays. MH Stoler PE Castle D Solomon M Schiffman, Am J Clin Pathol 2007 127 1 3 10.1309/RNF3C01JKADQCLKP
15. Can HPV-16 genotyping provide a benchmark for cervical biopsy specimen interpretation? MT Galgano PE Castle MH Stoler D Solomon M Schiffman, Am J Clin Pathol 2008 130 65 70 10.1309/A8MFC18TWANC8QFH 18550472
16. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. SJ Klug A Molijn B Schopp B Holz A Iftner W Quint P JF Snijders KU Petry S Krüger Kjaer C Munk T Iftner, J Med Virol 2008 80 1264 1274 10.1002/jmv.21191 18461626
17. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. LJ van Doorn W Quint B Kleter A Molijn B Colau MT Martin Kravang-In N Torrez-Martinez CL Peyton CM Wheeler, J Clin Microbiol 2002 40 979 983 11880426 10.1128/JCM.40.3.979-983. 2002
18. FDA Reclassification Order, Docket No. 2007P-0210. S Gutman, 2007 http://www.hifidna.com/News%20&%20Events%20files/Gutman+FDA.pdf
19. Classification of papillomaviruses. EM de Villiers C Fauquet TR Broker HU Bernard H zur Hausen, Virology 2004 324 17 27 10.1016/j.virol.2004.03.033 15183049
20. A two-tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens. JC Feoli-Fonseca LL Oligny M Filion P Brochu P Simard PA Russo WV Yotov, Diagn Mol Pathol 1998 7 317 323 10.1097/00019606-199812000-00005 10207670
21. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. SD Vernon ER Unger D Williams, J Clin Microbiol 2000 38 651 655 10655362 (Pubitemid 30082658)
22. Routine genotyping of human papillomavirus samples in Denmark. T Johnson K Bryder S Corbet A Fomsgaard, APMIS 2003 111 398 404 10.1034/j.1600-0463.2003. t01-1-1110204.x 12752219
23. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. N Speich C Schmitt R Bollmann M Bollmann, J Med Microbiol 2004 53 125 128 10.1099/jmm.0.05447-0 14729933
24. Type-specific detection of human papillomaviruses in a routine laboratory setting improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation. S Kosel S Burggraf J Mommsen W Engelhardt B Olgemoller, Clin Chem Lab Med 2003 41 787 791 10.1515/CCLM.2003.119 12880142
25. A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. T Asato T Maehama Y Nagai K Kanazawa H Uezato K Kariya, J Infect Dis 2004 189 1829 1832 10.1086/382896 15122519
26. Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories. SH Lee VS Vigliotti JS Vigliotti S Pappu, Infect Agent Cancer 2007 2 11 doi:10.1186/1750-9378-2-11 17550589 10.1186/1750-9378-2-11
27. DNA Sequencing Validation of Chlamydia trachomatis and Neisseria gonorrhoeae Nucleic Acid Tests. SH Lee VS Vigliotti S Pappu, Am J Clin Pathol 2008 129 852 859 10.1309/Y2202RVCGRWW1RWB 18480000
28. Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based Pap cytology specimen. SH Lee VS Vigliotti JS Vigliotti S Pappu, BMC Women's Health 2009 9 8 doi:10.1186/1472- 6874-9-8 19358733 10.1186/1472-6874-9-8
29. State must do more to prevent cervical cancer. D Hovey, http://www.housegop.ct.gov/%5Cpressrel%5CHoveyD112%5C2007%5C20070116-HoveyD112- 01.pdf
30. Human papillomavirus infection among women in a representative rural and suburban population of the United States. SH Lee VS Vigliotti S Pappu, Int J Gyn Ob 2009 105 210 214 10.1016/j.ijgo.2009.01.019
31. Type-specific multiple sequencing primers: a novel strategy for reliable and rapid genotyping of human papillomaviruses by pyrosequencing technology. B Gharizadeh M Oggionni B Zheng E Akom N Pourmand A Ahmadian KL Wallin P Nyren, J Mol Diagn 2005 7 198 205 15858143 (Pubitemid 40668302)
32. Gardasil HPV Quadrivalent Vaccine. VRBPAC Background Document, VRBPAC Meeting M18 2006 http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4222B3.pdf
33. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. KL Wallin F Wiklund T Angström F Bergman U Stendahl G Wadell G Hallmans J Dillner, N Engl J Med 1999 341 1633 1638 10.1056/NEJM199911253412201 10572150
34. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. SK Kjaer AJ van den Brule G Paull EI Svare ME Sherman BL Thomsen M Suntum JE Bock PA Poll CJ Meijers, BMJ 2002 325 572 576 12228133 10.1136/bmj.325.7364.572 (Pubitemid 35026129)
35. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. KS Cuschieri HA Cubie MW Whitley G Gilkison MJ Arends C Graham E McGoogan, J Clin Pathol 2005 58 946 950 16126875 10.1136/jcp.2004.022863
36. Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. O Brummer B Hollwitz G Bohmer H Kuhnle KU Petry, Gynecol Oncol 2006 102 517 522 10.1016/j.ygyno.2006.01.020 16483642
37. Inflammation, a key event in cancer development. H Lu W Ouyang C Huang, Mol Cancer Res 2006 4 221 233 10.1158/1541-7786.MCR-05-0261 16603636
38. Complete nucleotide sequence and analysis of a novel human papillomavirus (HPV 84) genome cloned by an overlapping PCR method. M Terai RD Burk, Virology 2001 279 109 115 10.1006/viro.2000.0716 11145894
39. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal Papanicolaou smears. M Schiffman CM Wheeler A Dasgupta D Solomon PE Castle The ALTS Group, Am J 2005 124 722 732 (Pubitemid 41532507)
40. Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types. S Menzo A Ciavattini P Bagnarelli K Marinelli S Sisti M Clementi, BMC Microbiol 2008 8 112 doi:10.1186/1471-2180-8-112 18601724 10.1186/1471-2180-8-112
41. Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. S Menzo A Monachetti C Trozzi A Ciavattini G Carloni PE Varaldo M Clementi, J Virol 2001 75 11913 11919 11689676 10.1128/JVI.75.23.11913-11919.2001